Literature DB >> 7000717

Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers.

G Johnsson, L Jordö, P Lundborg, C G Regårdh, O Rönn.   

Abstract

The bioavailability, plasma levels and pharmacological effect of a daily dose of 0.2 g of metoprolol in Durules and in regular 0.1 g tablets have been studied in eight healthy volunteers during steady state conditions. Durules and two 0.1 g metoprolol tablets were given once daily, and one 0.1 g metoprolol tablet was given every 12th hour. The maximum concentration of metoprolol in plasma after Durules was about half of that after two regular tablets. When one metoprolol 0.1 g tablet was administered every 12th hour, an average maximum concentration slightly higher than for the Durules was recorded about one hour after the administration. The minimum concentration of metoprolol during the day was about twice as high after Durules as after the same dose in regular tablets. The dose-corrected area under the plasma concentration vs time curve of Durules was 87 per cent of the b.i.d. regimen of metoprolol in regular tablets and about 75 per cent of two metoprolol 0.1 g tablets once daily. Metoprolol Durules maintained a more even effect on heart rate and systolic blood pressure during exercise during the day than the corresponding daily dose of metoprolol given as two metoprolol 0.1 g tablets once daily or as one metoprolol 0.1 g tablet every 12th hour. After maximum beta-blockade the effect declined by, on average, 0.60 per cent/hour for the Durules and 0.96 per cent for the regular tablet. The exercise heart rate before the morning dose was significantly lower during treatment with Durules and one metoprolol 0.1 g tablet b.i.d. than during the placebo period. The interaction of metoprolol with the effect of adrenaline (0.09 microgram x kg-1 x min-1, infused at 2, 3.5 and 5 hrs after metoprolol administration) on the diastolic blood pressure was more pronounced when two ordinary 0.1 g metoprolol tablets were administered once daily than for the corresponding dose in Durules, this probably reflecting a difference in degree of action of metoprolol on the vascular bed for Durules and regular metoprolol tablets in identical doses.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000717

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  12 in total

1.  Effect of controlled-release metoprolol on blood pressure and exercise heart rate in hypertension: a comparison with conventional tablets.

Authors:  L Rydén; B E Kristensson; G Westergren
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Haemodynamic effects of cigarette smoking during beta-adrenoceptor blockade.

Authors:  S Freestone; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

Review 3.  The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations.

Authors:  M S Lennard; G T Tucker; H F Woods
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

Review 4.  Oxidation phenotype and the metabolism and action of beta-blockers.

Authors:  M S Lennard
Journal:  Klin Wochenschr       Date:  1985-04-01

Review 5.  Genetically determined adverse drug reactions involving metabolism.

Authors:  M S Lennard
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

6.  Comparison of the duration of effect of metoprolol and a sustained release formulation of metoprolol (betaloc-SA).

Authors:  D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

7.  Long acting beta-blockers in the twenty fourth hour.

Authors:  G I Hackett; P Harrison; S Kershaw
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 8.  Controlled release metoprolol. Clinical pharmacokinetic and therapeutic implications.

Authors:  M J Kendall; S R Maxwell; A Sandberg; G Westergren
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

9.  A comparison of once daily atenolol and metoprolol SA in mild to moderate hypertension.

Authors:  C A Morley; C Cavalcanti; E J Perrins; R Sutton
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

10.  Pharmacokinetic and pharmacodynamic comparison of conventional and controlled release formulations of metoprolol [correction of motoprolol] in healthy Chinese subjects.

Authors:  Y T Lee; C S Liau; E C Wong; W J Chen; M F Chen; C C Chen
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.